Enter your email address in the box to the right of this page to receive email updates from the Life Sciences Hub when new content is published.
For those with an interest in life sciences, the rise to prominence of CRISPR, a transformational development in the field of molecular biology and genetics, has been impossible to ignore.
Welcome to our blog dedicated to Life Sciences. We report on EU and national regulatory, compliance, intellectual property and transactional developments in the sector. We focus on (bio)pharmaceuticals and medical technologies, and also cover food and beverages, cosmetics and other healthcare products.
02 August 2019 - Posted by: Nele De Backer
Last week, the Belgian and Italian consumer associations Test Aankoop/Test Achats and Altroconsumo filed complaints with their respective national competition authorities, alleging that the pharmaceutical group Biogen is abusing its dominant position by charging excessively high prices for the medicine Spinraza, which it has the exclusive right to market as an orphan drug until 2029. › Read More
29 July 2019 - Posted by: Francesca Miotto
Last week, the European Commission (EC) published its Report on Competition Policy 2018, which provides a non-exhaustive summary of the activities undertaken by the EC in the field of competition law and policy in the year 2018.Whilst this report does not specifically refer to the pharmaceutical sector, the accompanying Commission Staff Working Document, which was › Read More
11 July 2019 - Posted by: Eveline Van Keymeulen
Today is a big day for legal cannabis in France. Earlier this morning, the French National Agency for Medicines and Health Products Safety (ANSM) endorsed the medical cannabis pilot programme per the recommendations of the French specialised committee on cannabis (CSST) which were published on 28 June (see our earlier blog post: “French cannabis committee › Read More
02 July 2019 - Posted by: Tine Carmeliet
In Belgium, two recent events have drawn attention to the (online) pharmacy market. First, on 28 May 2019, the Competition Court of the Belgian Competition Authority (BCA) imposed a fine of EUR 1 million on the Belgian Order of Pharmacists for the use of anti-competitive practices aimed at excluding the MediCare-Market group, an association of (para)-pharmacies › Read More
01 July 2019 - Posted by: Laurie-Anne Ancenys
On 29 May 2019, the French National Ethical Consultative Committee for Life Sciences and Health (CCNE) delivered its Opinion (n°130) on ethical issues in connection with big data in the health sector (the Opinion). The Opinion aims at identifying the ethical challenges raised by the exploitation of large set of data in healthcare and provide › Read More